Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (2): 527-532.doi: 10.13481/j.1671-587X.20220233
• Review • Previous Articles Next Articles
-
Received:2021-04-20Online:2022-03-28Published:2022-05-10
CLC Number:
- Q75
Cite this article
share this article
| 1 | MITELMAN F， JOHANSSON B， MERTENS F. The impact of translocations and gene fusions on cancer causation［J］. Nat Rev Cancer， 2007， 7（4）：233-245. |
| 2 | MORIN S J， ECCLES J， ITURRIAGA A， et al. Translocations， inversions and other chromosome rearrangements［J］. Fertil Steril， 2017， 107（1）：19-26. |
| 3 | 张得芳. 染色体重排与物种分化［J］. 分子植物育种， 2017， 15（1）：279-289. |
| 4 | RAY-COQUARD I， SERRE D， REICHARDT P，et al. Options for treating different soft tissue sarcoma subtypes［J］. Future Oncol， 2018， 14（10s）：25-49. |
| 5 | BILL M， MRÓZEK K， KOHLSCHMIDT J， et al. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A［J］.Proc Natl Acad Sci U S A，2020， 117（42）：26340-26346. |
| 6 | KHAN M， SIDDIQI R， TRAN TH. Philadelphia chromosome-like acute lymphoblastic leukemia：A review of the genetic basis， clinical features，and therapeutic options［J］. Semin Hematol， 2018， 55（4）：235-241. |
| 7 | OSMAN A E G， DEININGER M W. Chronic myeloid leukemia： modern therapies， current challenges and future directions［J］. Blood Rev， 2021：100825. |
| 8 | SCHRÖDER J， KUMAR A， WONG S Q. Overview of fusion detection strategies using next-generation sequencing［J］. Methods Mol Biol， 2019， 1908：125-138. |
| 9 | STANGL C， DE BLANK S， RENKENS I， et al. Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing［J］. Nat Commun， 2020， 11（1）：2861. |
| 10 | WANG Y， WU N， LIU D， et al. Recurrent fusion genes in leukemia： an attractive target for diagnosis and treatment［J］. Curr Genomics， 2017， 18（5）：378-384. |
| 11 | Mertens F， Johansson B， Fioretos T， et al. The emerging complexity of gene fusions in cancer［J］. Nat Rev Cancer， 2015， 15（6）：371-381. |
| 12 | KIM P， ZHOU X. Fusion GDB： fusion gene annotation DataBase［J］.Nucl Acids Res，2019，47（D1）：D994-d1004. |
| 13 | NARDI V， KU N， FRIGAULT M J， et al. Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement［J］. Blood Adv， 2020， 4（1）：106-111. |
| 14 | BIELACK S S， COX M C， NATHRATH M， et al. Rapid， complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent， chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion［J］. Ann Oncol， 2019， 30（）：viii31-viii35. |
| 15 | DRILON A， LI G， DOGAN S， et al. What hides behind the MASC： clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma （MASC）［J］. Ann Oncol， 2016， 27（5）：920-926. |
| 16 | FRENCH C A. NUT carcinoma： Clinicopathologic features， pathogenesis， and treatment［J］. Pathol Int， 2018， 68（11）：583-595. |
| 17 | DE BRAEKELEER E， DOUET-GUILBERT N， DE BRAEKELEER M. RARA fusion genes in acute promyelocytic leukemia： a review［J］. Expert Rev Hematol， 2014， 7（3）：347-357. |
| 18 | NI X， HU G， CAI X. The success and the challenge of all-trans retinoic acid in the treatment of cancer［J］. Crit Rev Food Sci Nutr， 2019， 59（sup1）：S71-S80. |
| 19 | CLAUDIANI S， APPERLEY J F. The argument for using imatinib in CML［J］. Hematology Am Soc Hematol Educ Program， 2018， 2018（1）：161-167. |
| 20 | FRENCH C A. Pathogenesis of NUT midline carcinoma［J］. Annu Rev Pathol， 2012， 7：247-265. |
| 21 | PAPAEMMANUIL E， GERSTUNG M， BULLINGER L，et al.Genomic classification and prognosis in acute myeloid leukemia［J］. N Engl J Med， 2016， 374（23）：2209-2221. |
| 22 | WAGENER R， LÓPEZ C， KLEINHEINZ K， et al. IG-MYC （+） neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas［J］. Blood， 2018， 132（21）：2280-2285. |
| 23 | JANZ S. Myc translocations in B cell and plasma cell neoplasms［J］. DNA Repair （Amst）， 2006， 5（9/10）：1213-1224. |
| 24 | DANG C V. MYC on the path to cancer［J］. Cell， 2012， 149（1）：22-35. |
| 25 | LARMONIE N S， DIK W A， MEIJERINK J P， et al. Breakpoint sites disclose the role of the V（D）J recombination machinery in the formation of T-cell receptor （TCR） and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia［J］. Haematologica， 2013， 98（8）：1173-1184. |
| 26 | HAO X， BILLINGS S D， WU F， et al. Dermatofibrosarcoma protuberans： update on the diagnosis and treatment［J］. J Clin Med， 2020，9（6）：1752. |
| 27 | OTSUKA-MAEDA S， KAJIHARA I， KANEMARU H，et al. Retrospective study of COL1A1-PDGFB fusion gene-positive dermatofibrosarcoma protuberans in Kumamoto University［J］. Clin Exp Dermatol，2020， 45（8）：1067-1068. |
| 28 | KÖSTER J， ARBAJIAN E， VIKLUND B， et al. Genomic and transcriptomic features of dermatofibrosarcoma protuberans： Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development［J］. Cancer Genet， 2020， 241：34-41. |
| 29 | LI N， ZHOU T， CHEN S， et al. COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans： a useful diagnostic tool and clinicopathological analysis［J］. Int J Clin Exp Pathol， 2018， 11（8）：4052-4059. |
| 30 | MIETTINEN M， FELISIAK-GOLABEK A， LUIÑA CONTRERAS A， et al. New fusion sarcomas： histopathology and clinical significance of selected entities［J］. Hum Pathol， 2019， 86：57-65. |
| 31 | WANG Z， WANG Y， ZHANG J， et al. Significance of the TMPRSS2：ERG gene fusion in prostate cancer［J］. Mol Med Rep， 2017， 16（4）：5450-5458. |
| 32 | LIMSUWANACHOT N， KONGRUANG A， RERKAMNUAYCHOKE B， et al. Practical laboratory tools for monitoring of BCR-ABL1 transcripts and tyrosine kinase （TK） domain mutations in chronic myeloid leukemia patients undergoing TK inhibitor therapy： a single-center experience in thailand［J］. Asian Pac J Cancer Prev， 2020， 21（7）：2003-2012. |
| 33 | 赵 亮， 张 丽， 曾 强，等. ABL1相关融合基因与急性淋巴细胞性白血病关系的研究进展［J］. 中国慢性病预防与控制， 2016， 24（5）：383-386. |
| 34 | 郑 岚， 郑 浩， 姚晓玲. 白血病相关融合基因的研究进展 ［J］. 淮海医药， 2018， 36（5）：624-628. |
| 35 | LAXMI A， GUPTA P， GUPTA J. CCDC6， a gene product in fusion with different protoncogenes， as a potential chemotherapeutic target［J］. Cancer Biomark， 2019， 24（4）：383-393. |
| 36 | DE BRAEKELEER E， DOUET-GUILBERT N， ROWE D， et al. ABL1 fusion genes in hematological malignancies：a review［J］.Eur J Haematol，2011，86（5）：361-371. |
| 37 | SUNDARESH A.WILLIAMS O. Mechanism of ETV6-RUNX1 Leukemia［J］. Adv Exp Med Biol， 2017， 962：201-216. |
| 38 | 冯业成， 黄慧敏， 符垂师. 小儿急性髓性白血病的CDKN2A和CDKN2B的拷贝数变异情况分析 ［J］. 临床肿瘤学杂志， 2020， 25（9）：830-835. |
| 39 | SILVEIRA ZAVALHIA L， WEBER MEDEIROS A， OLIVEIRA SILVA A， et al. Do FHIT gene alterations play a role in human solid tumors？［J］. Asia Pac J Clin Oncol， 2018， 14（5）：e214-e223. |
| 40 | COLLIN A. NUT （nuclear protein in testis） ［J］. Atlas Genet Cytogenet Oncol Haematol， 2007，11（3）：207-208. |
| 41 | FRENCH C A. NUT midline carcinoma［J］. Cancer Genet Cytogenet， 2010， 203（1）：16-20. |
| 42 | CHIANG C M. Phospho-BRD4： transcription plasticity and drug targeting［J］. Drug Discov Today Technol， 2016， 19：17-22. |
| 43 | SAKAMAKI J I， WILKINSON S， HAHN M， et al. Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function［J］. Mol Cell， 2017， 66（4）：517-532.e519. |
| 44 | ALEKSEYENKO A A， WALSH E M， ZEE B M，et al.Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma［J］. Proc Natl Acad Sci U S A， 2017， 114（21）：E4184-E4192. |
| 45 | GRÜNEWALD T G， BERNARD V， GILARDI-HEBENSTREIT P，et al.Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite［J］. Nat Genet，2015， 47（9）：1073-1078. |
| 46 | SLANY R K. MLL fusion proteins and transcriptional control［J］. Biochim Biophys Acta Gene Regul Mech， 2020， 1863（3）：194503. |
| 47 | SWART L E， HEIDENREICH O. The RUNX1/RUNX1T1 network： translating insights into therapeutic options［J］. Exp Hematol， 2021，94：1-10. |
| 48 | FU L， SHI J， LIU A， et al. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t（8；21） acute myeloid leukemia［J］. Int J Cancer， 2017， 140（3）：653-661. |
| 49 | AL-HARBI S， ALJURF M， MOHTY M， et al. An update on the molecular pathogenesis and potential therapeutic targeting of AML with t（8；21）（q22；q22.1）；RUNX1-RUNX1T1［J］.Blood Adv，2020，4（1）：229-238. |
| 50 | NAPOLITANO M， VENTURELLI M， MOLINARO E，et al. NUT midline carcinoma of the head and neck： current perspectives［J］. Onco Targets Ther， 2019， 12：3235-3244. |
| 51 | ZHANG X， ZEGAR T， LUCAS A， et al. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma［J］. Oncogene， 2020， 39（24）：4770-4779. |
| 52 | OTSUBO R， MUSSAZHANOVA Z， AKAZAWA Y， et al. Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl： a case report and review of literature［J］. J Pediatr Endocrinol Metab， 2018， 31（4）：461-467. |
| 53 | WU B， LOH T K S， VANECEK T， et al. （Mammary Analogue） Secretory carcinoma of the nasal cavity： report of a rare case with p63 and DOG1 expression and uncommon exon 4-exon 14 ETV6-NTRK3 fusion diagnosed with next generation sequencing［J］. Head Neck Pathol， 2020， 14（2）：542-549. |
| [1] | WANG Jiaxin, WU Ning, JIN Shunzi, WANG Yanjun, ZHANG Xuan. Associations between human plasma anti-gliadin antibodies and occurrence of schizophrenia in patients with different ages [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1263-1268. |
| [2] | LI Xin, MA Yunfei, TANG Geng, WEI Qi, JI Hongchi, TIAN Jiaan, SHEN Yannan, WANG Zhicheng. Enhancement of ROS induced by mitochondria-targeted KillerRed in proliferation inhibition of radiation on HeLa cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 718-723. |
| [3] | PANG Chunyan, WANG Hui, WANG Zhihua, FENG Xiuyuan, WANG Yongfu. Effect of co-expression of IL-10 and sleeping beauty transposon on balance of Th17/Treg cells in splenocytes of NOD mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 205-210. |
| [4] | Analysis on association between anti-gliadin IgA and anti-gliadin IgG antibodies and schizophrenia in Chinese Han population. Analysis on association between anti-gliadin IgA and anti-gliadin IgG antibodies and schizophrenia in Chinese Han population [J]. Journal of Jilin University Medicine Edition, 2014, 40(05): 1051-1057. |
| [5] | XU Hong-qin1，WANG Chong，ZHOU Jie，SONG Hai-yan,LIU Ri-hui，ZHANG Qing-qing，SHI Jie-ping，YU Ya-qin，LIU Ya-wen. Association between PLA2G4C minisatellite polymorphism and schizophrenia [J]. Journal of Jilin University Medicine Edition, 2014, 40(04): 824-827. |
| [6] | YANG Xue-ling,DING Yan-hua,LI Qing-mei,XU Shan-shan,XU Xiu-zhi,YANG Si-jia. Association between HLA-DRB1 SNPs |and cerebrovascular disease in Han population from North China [J]. J4, 2011, 37(5): 867-872. |
| [7] | YI Lin . Analysis on association between urotensin ⅡS89N gene polymorphisms and serum lipid level in essential hypertension patients in Dongxiang population [J]. J4, 2011, 37(5): 890-893. |
| [8] | WANG Xue-na|MA Ning|ZHANG Jing-ying|MA Shu,ZHANG Yan-dong|WANG Kai,JIANG Zheng-y. Analysis on polymorphism of killer cell immunoglobulin-like receptor genes in Han population of Jilin province [J]. J4, 2011, 37(4): 718-722. |
| [9] | . Influence of PTEN on proliferation of colon cancercell HCT-8 by siRNA [J]. J4, 2011, 37(2): 231-235. |
| [10] | ZHANG Shu-Fang, ZHANG Ying-Ai, WANG Shun-Lan, DENG Xiang-Dong, XIAO Jing-Chuan, YU Ping. Clinical and molecular biological characteristics of patients in a MYH9-RD family [J]. J4, 2011, 37(1): 109-112. |
| [11] | ZHAO Li-Jing, XUDuo, CHENG Hong, LIANG Zuo-Wen, LU Yu-Ming, HAN Xiang-Bei, GUO Ya-Xiong, ZHAO Li-Juan, DONG Yan. Effects of 20(s)-proto-panaxdiol oncaspase-3 expression and activation in Siha cells in vitro [J]. J4, 2011, 37(1): 26-29. |
| [12] | XU Duo, ZHAO Li-Jing, CHENG Hong, GUO Ya-Xiong, HAN Xiang-Bei, LU Yu-Ming, ZHAO Li-Juan, DONG Yan. Effect of 20(S)〖KG-*3〗-proto-panaxdiol on autophag [J]. J4, 2010, 36(6): 1055-1058. |
| [13] | YU Qiong,FU Ying-li,FENG Jia,XIE Bing,KOU Chang-gui,YU Ya-qin. Meta analysis |on |relationship between 5-hydroxytryptamine 1A receptor gene polymorphism and suicide [J]. J4, 2010, 36(6): 1134-1138. |
| [14] | ZHAO Li-Jing, XU Duo, LIANG Zuo-Wen, CHENG Hong, GUO Ya-Xiong, LI De-Long, HAN Xiang-Bei, ZHAO Li-Juan, DONG Yan. Effect of 20(s)-proto-panaxdiol on apoptosis of Siha cells in vitro [J]. J4, 2010, 36(2): 345-348. |
| [15] | WANG Jiao-Yan, ZHANG Li, WU Jiang, LIU Yang, WANG Zhen-Qi, GUAN Song-Lei, YOU Yang, ZHANG Xuan. Association analysis on TNXB gene polymorphisms |and schizophrenia in Chinese Han population [J]. J4, 2010, 36(2): 359-363. |
|
||